Addison-based Cannabis Science ramps up awareness leading to magical day, April 20

by PegNews wire

ADDISON — Cannabis Science, Inc. announced its 420 Commemorative Certificate Program and that it has engaged Capital Structure Today to provide it with branding and public/investor awareness services.

April 20 is the New Year's Day of cannabis culture. Activists, recreational users and other socially conscious members of the world-wide community stop their work or play at 4:20 p.m. and share in an herbal communion. In recognition of the importance and relevance of this day to our Company’s mission, we’ve launched our 420 Commemorative Certificate Program. Shareholders who own the Company’s common stock on April 20 are eligible to purchase a limited edition Commemorative Certificate from our transfer agent, Routh Stock Transfer, Inc., properly framed and righteously dated. A specimen sample certificate and instructions to obtain your Commemorative Certificate will be posted to our Web site in the next few days after final approval of the artwork. The 420 Commemorative Certificate Program will be limited to 500 certificates this year, each hand signed by President Steven W. Kubby.

Vice President and Chief Financial Officer Richard Cowan stated, “During my tenure as National Director of NORML, we looked forward to April 20 each year to re-commit the activist community and re-connect with the recreational user and others who shared the national organization’s goals. For the last 30 years, 420 has been an integral part of cannabis culture, and I know that NORML still emphasizes its observance for lots of reasons and in lots of venues. Here at Cannabis Science, Inc., our commercial goal is to develop and market FDA-approved and OTC cannabis-based medicines employing our proprietary lozenge delivery system. This goal stands on the foundation that our President, Steve Kubby, NORML and other cannabis activist organizations have built on a state-by-state basis, a large part of which has been based on the recognition and advancement of the clinical use of medical marijuana for a broad range of illnesses and for general health maintenance. We want to approach these issues from a commercial, profit-driven objective. That said, 420 is an important reminder for all of us to keep the faith and build bridges to those that don’t yet see things the way we do, and we think the 420 Commemorative Certificate is a great reminder that our shareholders will appreciate all year long.”

CST’s work will be predominantly oriented toward social networking with financial professionals and medical cannabis activists. The firm has extensive follows, friends, streams and fans in Twitter, MySpace, Plurk and Facebook, as well as competence in establishing and maintaining groups in Digg, Stumbleupon and others.

Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. They're dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Source: Cannabis Science

• Staff
• Verified User
• Anonymous